- Oncolytic virus therapy in cancer: A current review
Jonathan Santos Apolonio et al, 2021, World Journal of Virology CrossRef - A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
Ann W. Silk et al, 2023, Cancer Immunology, Immunotherapy CrossRef - The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
Luyao Wang et al, 2022, Frontiers in Oncology CrossRef - Trial Watch—Oncolytic viruses and cancer therapy
Jonathan Pol et al, 2016, OncoImmunology CrossRef - Oncolytic immunotherapy: The new clinical outbreak
Jean-François Fonteneau et al, 2016, OncoImmunology CrossRef - Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration
Zinnia P. Parra-Guillen et al, 2021, Frontiers in Pharmacology CrossRef - Oncolytic virus preclinical toxicology studies
Agnija Rasa et al, 2023, Journal of Applied Toxicology CrossRef - Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
Yi-Ying Wu et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef - A physiologically based pharmacokinetic model for V937 oncolytic virus in mice
Sara Peribañez-Dominguez et al, 2023, Frontiers in Pharmacology CrossRef - The Effects of Mesenchymal Stem Cells Loaded with Oncolytic Coxsackievirus A21 on Mouse Models of Colorectal Cancer
Reza Karbalaee et al, 2024, Current Cancer Drug Targets CrossRef